BM41
- Generic Name
- BM41
S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen
Phase 1
Completed
- Conditions
- Birch Pollen AllergyAllergic Rhinoconjunctivitis
- Interventions
- First Posted Date
- 2021-06-03
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- Odense University Hospital
- Target Recruit Count
- 47
- Registration Number
- NCT04912076
- Locations
- 🇩🇰
Odense Research Center for Anaphylaxis, Odense University Hospital, Odense, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath